Royal Bank of Canada’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,760
| Closed | -$17K | – | 7432 |
|
|
2019
Q1 | $17K | Sell |
3,760
-4,570
| -55% | -$21.6K | ﹤0.01% | 5742 |
|
|
2018
Q4 | $29K | Sell |
8,330
-22,005
| -73% | -$153K | ﹤0.01% | 5406 |
|
|
2018
Q3 | $306K | Sell |
30,335
-55
| -0.2% | -$439 | ﹤0.01% | 4229 |
|
|
2018
Q2 | $220K | Sell |
30,390
-2,484
| -8% | -$17.3K | ﹤0.01% | 4355 |
|
|
2018
Q1 | $199K | Sell |
32,874
-1,955
| -6% | -$16.1K | ﹤0.01% | 4326 |
|
|
2017
Q4 | $335K | Buy |
34,829
+5,727
| +20% | +$37.5K | ﹤0.01% | 4086 |
|
|
2017
Q3 | $258K | Buy |
29,102
+15,407
| +113% | +$159K | ﹤0.01% | 4327 |
|
|
2017
Q2 | $173K | Buy |
13,695
+6,877
| +101% | +$81.4K | ﹤0.01% | 4452 |
|
|
2017
Q1 | $72K | Buy |
6,818
+4,370
| +179% | +$46.6K | ﹤0.01% | 4952 |
|
|
2016
Q4 | $23K | Sell |
2,448
-497
| -17% | -$5.62K | ﹤0.01% | 5704 |
|
|
2016
Q3 | $34K | Buy |
2,945
+662
| +29% | +$10.1K | ﹤0.01% | 5338 |
|
|
2016
Q2 | $29K | Sell |
2,283
-103
| -4% | -$1.5K | ﹤0.01% | 5358 |
|
|
2016
Q1 | $38K | Buy |
2,386
+1,639
| +219% | +$31.1K | ﹤0.01% | 5248 |
|
|
2015
Q4 | $21K | Sell |
747
-1,213
| -62% | -$33.6K | ﹤0.01% | 5702 |
|
|
2015
Q3 | $56K | Sell |
1,960
-8,828
| -82% | -$325K | ﹤0.01% | 5071 |
|
|
2015
Q2 | $387K | Buy |
10,788
+10,598
| +5,578% | +$330K | ﹤0.01% | 3852 |
|
|
2015
Q1 | $6K | Sell |
190
-2,660
| -93% | -$70.3K | ﹤0.01% | 5708 |
|
|
2014
Q4 | $60K | Sell |
2,850
-1,150
| -29% | -$22.7K | ﹤0.01% | 4977 |
|
|
2014
Q3 | $78K | Buy |
4,000
+800
| +25% | +$12.6K | ﹤0.01% | 4741 |
|
|
2014
Q2 | $50K | Sell |
3,200
-250
| -7% | -$4.04K | ﹤0.01% | 4843 |
|
|
2014
Q1 | $71K | Buy |
3,450
+1,950
| +130% | +$38.7K | ﹤0.01% | 4707 |
|
|
2013
Q4 | $19K | Sell |
1,500
-26,952
| -95% | -$374K | ﹤0.01% | 5281 |
|
|
2013
Q3 | $332K | Buy |
+28,452
| New | +$234K | ﹤0.01% | 3715 |
|
Other funds holding INSY
WS
Royal Bank of Canada's INSY Position: Q2 2019 in Review
Royal Bank of Canada sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 3,760 shares — an estimated $17K sold.
Royal Bank of Canada first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $387K in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Royal Bank of Canada reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Royal Bank of Canada sold 3,760 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $17K.
- Royal Bank of Canada first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
- Royal Bank of Canada's Insys Therapeutics, Inc. position peaked at $387K in Q2 2015.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Royal Bank of Canada's 13F filing for Q2 2019, filed 14 Aug 2019.